Clinical Features and Outcomes of Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid (DPP4i-Associated BP) in Thai Patients

<div>(a) Disseminated bullous pemphigoid and a close up image of bullae on the chest wall in Case no.4 before sitagliptin withdrawal and (b) improvements of skin lesions in this patient after 2 weeks of sitagliptin discontinuation.</div>

Case Reports in Endocrinology

fig3

Figure 3

Figure 3: Clinical Features and Outcomes of Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid (DPP4i-Associated BP) in Thai Patients 